Clinical Data Behind CAR T-Cell Therapies in ALL – OncLive
OncLive |
Clinical Data Behind CAR T-Cell Therapies in ALL
OncLive David Maloney, MD, PhD: Yes, I think there's one practical issue that people always ask me: How to you measure the CAR? Well you don't actually really have to measure the CAR if you monitor the patient for B-cell recovery. So, if you see CD19-positive … |
